Targeting the Immunogenetic Diseases with the Appropriate HLA Molecular Typing: Critical Appraisal on 2666 Patients Typed in One Single Centre

<table>Principal component analysis of HLA-DRB1 in uveitis, rheumatoid arthritis (RA), adult bone marrow donors (BMD), and cord blood donors (CBD).</table>

BioMed Research International

fig3

Figure 3

Figure 3: Targeting the Immunogenetic Diseases with the Appropriate HLA Molecular Typing: Critical Appraisal on 2666 Patients Typed in One Single Centre 

Figure 3 | Targeting the Immunogenetic Diseases with the Appropriate HLA Molecular Typing: Critical Appraisal on 2666 Patients Typed in One Single Centre 